LEVOTHYROXINE SODIUM
| Brand name | LEVOLET |
|---|---|
| Active ingredient | LEVOTHYROXINE SODIUM |
| Strength | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2003 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10231931 | March 2038 | product |
| 10406108 | March 2038 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.